TNDM:NASDAQ
Tandem Diabetes Care Inc
16,37Â US$
arrow_downward
-0,91%(-0,15) 1D
6 tet, 1:04:23 m.d., GMT-4 · USD
search
TĂ« gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për TNDM...
Hap
16,77Â US$
I lartë
17,05Â US$
I ulët
16,31Â US$
Kapitalizimi i tregut
1,14Â mld
VĂ«llimi mesatar
1,93Â mln
VĂ«llimi
445,72 mijë
Maksimumi 52-javor
29,65Â US$
Minimumi 52-javor
12,26Â US$
Fitimet për aksion
-0,93Â US$
Beta
1,66
Aksionet në qarkullim
69,58Â mln
Numri i punonjësve
2 mijë
Hap
16,77Â US$
I lartë
17,05Â US$
I ulët
16,31Â US$
Kapitalizimi i tregut
1,14Â mld
VĂ«llimi mesatar
1,93Â mln
VĂ«llimi
445,72 mijë
Maksimumi 52-javor
29,65Â US$
Minimumi 52-javor
12,26Â US$
Fitimet për aksion
-0,93Â US$
Beta
1,66
Aksionet në qarkullim
69,58Â mln
Numri i punonjësve
2 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
AD HOC NEWS
·
1 ditë më parë
Tandem Diabetes Care stock gains 2.36 percent before Q3 results
Profili
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Rreth Tandem Diabetes Care Inc
Drejtori ekzekutivJohn Sheridan
Punonjësit2,5 mijë
Themeluar mëjan 2006
Selia-
SektoriMedical device
Uebsajtitandemdiabetes.com